Arterial thrombosis: relevance of a model with two levels of severity assessed by histologic, ultrastructural and functional characterization

Denis, 2007, Platelet adhesion receptors and their ligands in mouse models of thrombosis, Arterioscler Thromb Vasc Biol, 27, 728, 10.1161/01.ATV.0000259359.52265.62 Nieswandt, 2005, Platelets in atherothrombosis: lessons from mouse models, J Thromb Haemost, 3, 1725, 10.1111/j.1538-7836.2005.01488.x Sachs, 2007, In vivo thrombus formation in murine models, Circ Res, 100, 979, 10.1161/01.RES.0000261936.85776.5f Day, 2004, Murine thrombosis models, Thromb Haemost, 92, 486, 10.1055/s-0037-1613739 Denis, 1998, A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis, Proc Natl Acad Sci USA, 95, 9524, 10.1073/pnas.95.16.9524 Kurz, 1990, Rat model of arterial thrombosis induced by ferric chloride, Thromb Res, 60, 269, 10.1016/0049-3848(90)90106-M Matsuno, 1991, Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue‐type plasminogen activator with use of this model, J Pharmacol Methods, 25, 303, 10.1016/0160-5402(91)90030-9 Westrick, 2007, Murine models of vascular thrombosis (Eitzman series), Arterioscler Thromb Vasc Biol, 27, 2079, 10.1161/ATVBAHA.107.142810 Lindner, 1990, Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries, J Clin Invest, 85, 2004, 10.1172/JCI114665 Falati, 2002, Real‐time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse, Nat Med, 8, 1175, 10.1038/nm782 Furie, 2008, Mechanisms of thrombus formation, N Engl J Med, 359, 938, 10.1056/NEJMra0801082 Gachet, 2006, [Atherothrombosis: transposition of the models to the clinic and reciprocally], Therapie, 61, 389, 10.2515/therapie:2006067 Nonne, 2005, Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity, Arterioscler Thromb Vasc Biol, 25, 1293, 10.1161/01.ATV.0000163184.02484.69 Celi, 2003, Thrombus formation: direct real‐time observation and digital analysis of thrombus assembly in a living mouse by confocal and widefield intravital microscopy, J Thromb Haemost, 1, 60, 10.1046/j.1538-7836.2003.t01-1-00033.x Kalia, 2008, Critical role of FcR gamma‐chain, LAT, PLCgamma2 and thrombin in arteriolar thrombus formation upon mild, laser‐induced endothelial injury in vivo, Microcirculation, 15, 325, 10.1080/10739680701728822 Dubois, 2007, Thrombin‐initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model, J Clin Invest, 117, 953, 10.1172/JCI30537 Dubois, 2006, Glycoprotein VI‐dependent and ‐independent pathways of thrombus formation in vivo, Blood, 107, 3902, 10.1182/blood-2005-09-3687 Marx, 2008, Altered thrombus formation in von Willebrand factor‐deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa, Blood, 112, 603, 10.1182/blood-2008-02-142943 Lenain, 2003, Inhibition of localized thrombosis in P2Y1‐deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist, J Thromb Haemost, 1, 1144, 10.1046/j.1538-7836.2003.00144.x Moog, 2001, Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation, Blood, 98, 1038, 10.1182/blood.V98.4.1038 Gibbins, 2004, Platelet adhesion signalling and the regulation of thrombus formation, J Cell Sci, 117, 3415, 10.1242/jcs.01325 Hechler, 2006, MRS2500 [2‐iodo‐N6‐methyl‐(N)‐methanocarba‐2′‐deoxyadenosine‐3′,5′‐bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice, J Pharmacol Exp Ther, 316, 556, 10.1124/jpet.105.094037 Nieswandt, 2001, Long‐term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice, J Exp Med, 193, 459, 10.1084/jem.193.4.459 Rabie, 2007, Diverging signaling events control the pathway of GPVI down‐regulation in vivo, Blood, 110, 529, 10.1182/blood-2006-11-058107 Mangin, 2006, Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency, Blood, 107, 4346, 10.1182/blood-2005-10-4244 Strassel, 2007, Decreased thrombotic tendency in mouse models of the Bernard‐Soulier syndrome, Arterioscler Thromb Vasc Biol, 27, 241, 10.1161/01.ATV.0000251992.47053.75 Schulte, 2006, Two‐phase antithrombotic protection after anti‐glycoprotein VI treatment in mice, Arterioscler Thromb Vasc Biol, 26, 1640, 10.1161/01.ATV.0000225697.98093.ed Munnix, 2005, The glycoprotein VI‐phospholipase Cgamma2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo, Arterioscler Thromb Vasc Biol, 25, 2673, 10.1161/01.ATV.0000193568.71980.4a Lecut, 2005, Fibrillar type I collagens enhance platelet‐dependent thrombin generation via glycoprotein VI with direct support of alpha2beta1 but not alphaIIbbeta3 integrin, Thromb Haemost, 94, 107, 10.1160/TH04-12-0783 Van Der Meijden, 2009, Dual role of collagen in factor XII‐dependent thrombus formation, Blood, 114, 881, 10.1182/blood-2008-07-171066 Konstantinides, 2006, Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis, J Thromb Haemost, 4, 2014, 10.1111/j.1538-7836.2006.02086.x Chou, 2004, Hematopoietic cell‐derived microparticle tissue factor contributes to fibrin formation during thrombus propagation, Blood, 104, 3190, 10.1182/blood-2004-03-0935 Mizuno, 1992, Angioscopic evaluation of coronary‐artery thrombi in acute coronary syndromes, N Engl J Med, 326, 287, 10.1056/NEJM199201303260502 Aleil, 2003, Increased plasma levels of soluble platelet glycoprotein V in patients with acute myocardial infarction, J Thromb Haemost, 1, 1846, 10.1046/j.1538-7836.2003.00319.x Mackman, 2008, Triggers, targets and treatments for thrombosis, Nature, 451, 914, 10.1038/nature06797 Bhatt, 2009, Role of antiplatelet therapy across the spectrum of patients with coronary artery disease, Am J Cardiol, 103, 11A, 10.1016/j.amjcard.2008.11.018